Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

31
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
31
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.1K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.1K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.7K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.4K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

804
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
804
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

653
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
653

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of nutritional status on 30-days postoperative morbidity and mortality in patients undergoing emergency laparotomy for gastrointestinal perforation peritonitis: a prospective observational study.

BMC surgery·2026
Same author

Evidence-Based Translational Strategy of Medicated Topical Gel for Diabetic Wound Management.

Pharmaceutics·2026
Same author

Top 5 Advances in Global Education in Surgery Over the Last 50 Years.

World journal of surgery·2026
Same author

Resonator-based add-drop filters enabled by flexible polymorphic crystals with TADF-RTP motifs.

Chemical science·2026
Same author

Cyclic γ-AApeptide-Based Molecular Glues for RNA m<sup>6</sup>A Editing.

ACS chemical biology·2026
Same author

SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection <i>in vitro</i> and <i>in vivo</i>.

Frontiers in immunology·2026
Same journal

Genetic Evidence for Adiposity-Related Susceptibility and Heel BMD-Proxied Skeletal Resilience in Charcot Foot: A Two-Sample Mendelian Randomization Study.

The international journal of lower extremity wounds·2026
Same journal

Metabolic Intensification in Limb Salvage: A Doubly Robust Dual-Center Study Establishing 37.9 g/L as the Physiological Requirement for Diabetic Foot Ulcer Regeneration.

The international journal of lower extremity wounds·2026
Same journal

Efficacy and Safety of Kangfuxin Liquid Adjuvant Therapy Versus Standard Dressing in Treating Stage II-III Pressure Ulcers: A Meta-Analysis of Randomized Controlled Trials.

The international journal of lower extremity wounds·2026
Same journal

Revealing the Association Between Dietary Quality index and Diabetic Foot Ulcer: A Case-Control Study.

The international journal of lower extremity wounds·2026
Same journal

SGLT-2 Inhibitors and Lower-limb Amputations in Diabetes: A Misunderstood Relationship? Insights from a Retrospective Study.

The international journal of lower extremity wounds·2026
Same journal

Comparison of Safe Laser 1800 Infra and Standard Treatment for Chronic Non-Healing Wounds.

The international journal of lower extremity wounds·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
10:45

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

Published on: June 13, 2018

11.3K

The Buruli Ulcer.

Satendra Kumar1, Somprakas Basu1, Satyanam Kumar Bhartiya1

  • 1Banaras Hindu University, Varanasi, India.

The International Journal of Lower Extremity Wounds
|August 20, 2015
PubMed
Summary
This summary is machine-generated.

Buruli ulcer, a skin disease caused by Mycobacterium ulcerans, affects children in rural areas. Early diagnosis via PCR and prevention are key to managing this debilitating condition.

Keywords:
Buruli ulcerMycobacterium ulceransWorld Health Organizationantibioticspolymerase chain reaction

Related Experiment Videos

Last Updated: Apr 5, 2026

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
10:45

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

Published on: June 13, 2018

11.3K

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Microbiology

Background:

  • Buruli ulcer (BU) is a neglected tropical disease caused by Mycobacterium ulcerans.
  • It presents as skin ulcers or nodules, potentially leading to severe limb deformities and osteoarthritis.
  • Prevalent in rural areas, BU disproportionately affects children under 15.

Purpose of the Study:

  • To summarize the key aspects of Buruli ulcer, including its cause, transmission, diagnosis, and management.
  • To highlight the challenges in controlling BU, especially in co-endemic regions with HIV.

Main Methods:

  • Review of existing literature on Mycobacterium ulcerans and Buruli ulcer.
  • Discussion of diagnostic methods, including IS2404 polymerase chain reaction (PCR).
  • Overview of treatment strategies and prevention methods.

Main Results:

  • Mycobacterium ulcerans infection causes Buruli ulcer, with transmission possibly via skin lesions.
  • IS2404 PCR offers rapid confirmation of BU from clinical samples.
  • HIV co-infection can exacerbate BU, leading to aggressive osteomyelitis.

Conclusions:

  • Effective management of Buruli ulcer relies on early diagnosis and medical treatment with antitubercular drugs.
  • Surgery is reserved for complicated cases.
  • Given the lack of effective vaccination, primary prevention is crucial for Buruli ulcer control.